Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
ABCA7 (ATP binding cassette subfamily A member 7) encodes a multi‑pass transmembrane full‑size ABC‑A subfamily lipid transporter protein predominantly localised to plasma‑membrane compartments, with minor protein fractions detected within intracellular membrane‑bound vesicular structures. This transporter protein occurs across multiple organ‑derived tissue populations and displays distinct, tissue‑biased expression profiles, with enriched signals within immune‑related compartments and subsets of nervous‑system tissues. Distinct from soluble intracellular polypeptides, it bears multiple transmembrane helical segments together with large extracellular structural domains and conserved cytoplasmic nucleotide‑binding modules responsible for energy‑dependent conformational cycling and partner engagement. It acts as a membrane‑embedded transporter subunit, assembling with adjacent membrane‑resident partner components to form lipid‑transport‑competent molecular assemblies under physiological states. Insufficient ABCA7 protein abundance may impair normal membrane‑associated transporter‑partner complex assembly and disturb downstream cellular membrane‑adaptive behaviours. ABCA7 may exert molecular buffering functions to sustain suitable lipid‑dependent molecular configurations within cell populations. Diverse cellular physiological and substrate‑responsive phases bring shifting membrane‑lipid homeostasis demands, requiring varied transmembrane transporter proteins to maintain multicellular tissue physiological equilibrium. Membrane‑anchored ABCA7 assembles with partner membrane‑resident protein units to counteract abnormal transporter‑complex rearrangements and preserve stable plasma‑membrane functional states.
Sequence‑level alterations to the ABCA7 locus may compromise the structural organisation of assembled plasma‑membrane transporter‑partner complexes and alter readouts derived from cell‑surface molecular interaction events. Closely related members of ABC‑A transporter subfamily cannot fully replicate the complete set of ABCA7‑dependent behaviours during heteromeric transporter‑complex formation and stable integration within plasma‑membrane assemblies. Shifts in ABCA7 protein levels often align with cellular demands for membrane‑lipid‑related activities, making this protein a useful research target to explore ABC‑A‑subfamily transporter activities and membrane‑lipid‑balance molecular dynamics. Predominantly distributed at plasma‑membrane together with minor intracellular membrane fractions, ABCA7 contributes to heteromeric transporter‑complex formation and does not sustain persistent substrate translocation without appropriate energy‑driven conformational triggering. Its multi‑modular multi‑transmembrane ABC‑A transporter architecture with cytoplasmic nucleotide‑binding domains distinguishes this glycoprotein from many other membrane‑embedded surface components; such structural features support the maintenance of membrane‑transporter complex arrangement and permit selective physical contacts with cell‑surface binding partners. Diminished functional performance of ABCA7 may disturb the proper arrangement of plasma‑membrane transporter assemblies and weaken endogenous cellular adaptive buffering capacity, further supporting its research value for studies focused on ABC‑A‑type lipid transporter components.
Fig. 1 Schematic topology of ABC-A-subfamily transporter subunit, showing conserved TMD, ECD and NBD domain arrangement. This is a general family model, not experimentally verified exclusively for ABCA7.1
The biological functions of transmembrane ABCA7 transporter protein are focused on sustained heteromeric partner-complex interaction and plasma-membrane-homeostasis coordination:
Creative Biolabs offers purified ABCA7 membrane samples produced under unified preparation workflows, including full-length ABCA7 constructs and isolated domain variants. Truncated domain fragments cannot support complete surface-partner-complex assembly behaviours, while full-length constructs suit research focused on transporter-subunit-partner interaction and plasma-membrane anchoring functional observation. All batches receive uniform quality screening. Functional-relevant observation may only be carried out with full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length ABCA7 samples retain intact partner-interaction-domain conformation after standardized purification, which supports reliable detection of weak and transient subunit-partner contacts for comparative functional analysis.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable ABCA7 expression cell research models with varied expression levels, applicable to structural observation of multi-pass transmembrane ABC-A-subfamily lipid-transporter proteins and research into membrane-partner molecular interaction. Sample evaluation includes sustained target expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of subunit-binding behaviours under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-ABCA7 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane localization mapping and identification of subunit-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within membrane-enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for ABCA7 research:
ABCA7 might act as a multi-pass transmembrane ABC-A-subfamily lipid-transporter protein and participate in heteromeric plasma-membrane complex assembly to modulate membrane-transporter-complex arrangement and plasma-membrane homeostasis.
ABCA7 expression status could alter membrane-partner-complex assembly efficiency and local plasma-membrane-coupled molecular-interaction balance, serving as a major transporter mediator of membrane-lipid-homeostasis-associated biological processes.
No, ABCA7-associated research reagents from Creative Biolabs are exclusively built for exploring membrane-transporter-dependent plasma-membrane lipid-regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length ABCA7 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on plasma-membrane homeostasis and membrane-transporter-mediated membrane-partner perception.
Laboratory observation schemes may include subunit-partner interaction related tests to analyse molecular-binding associated behaviors under simulated plasma-membrane environments.
